Cargando…
Management of Massive Rivaroxaban Overdose With Acetaminophen and Isosorbide Mononitrate Overdose
Direct oral anticoagulants (DOACs) have been used more frequently for the prevention and management of thromboembolic disease in comparison to their predecessors. DOACs provide greater ease of administration, shorter half-lives, less monitoring, and fewer drug-drug interactions. With the rise of DOA...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939290/ https://www.ncbi.nlm.nih.gov/pubmed/36814751 http://dx.doi.org/10.7759/cureus.34019 |
_version_ | 1784890813763813376 |
---|---|
author | Casey, Bradley Daniels, Abigail Bahekar, Amol Patel, Divyang Chapa-Rodriguez, Alejandro |
author_facet | Casey, Bradley Daniels, Abigail Bahekar, Amol Patel, Divyang Chapa-Rodriguez, Alejandro |
author_sort | Casey, Bradley |
collection | PubMed |
description | Direct oral anticoagulants (DOACs) have been used more frequently for the prevention and management of thromboembolic disease in comparison to their predecessors. DOACs provide greater ease of administration, shorter half-lives, less monitoring, and fewer drug-drug interactions. With the rise of DOACs such as rivaroxaban, the opportunity for abuse also increases. Therefore, standardization of care based on rivaroxaban misuse must also be explored, an area in which there is not ample information. We present a case where a patient consumed a stockpile of her home medications in hopes to commit suicide. A 64-year-old female presented to the emergency department due to the ingestion of rivaroxaban 5,000 mg along with ingestion of acetaminophen 30,000 mg and isosorbide mononitrate 1000 mg in the setting of intentional self-harm with multiple declarations of being classified as Do Not Resuscitate. There have been documented cases of rivaroxaban overdose, however, there are no documented cases with levels of ingestion reaching 5,000 mg along with signs of severe bleeding. Our case study reviews the previously documented management of rivaroxaban abuse and the treatment that was given to our patient in the setting of extreme anticoagulant ingestion. |
format | Online Article Text |
id | pubmed-9939290 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-99392902023-02-21 Management of Massive Rivaroxaban Overdose With Acetaminophen and Isosorbide Mononitrate Overdose Casey, Bradley Daniels, Abigail Bahekar, Amol Patel, Divyang Chapa-Rodriguez, Alejandro Cureus Cardiology Direct oral anticoagulants (DOACs) have been used more frequently for the prevention and management of thromboembolic disease in comparison to their predecessors. DOACs provide greater ease of administration, shorter half-lives, less monitoring, and fewer drug-drug interactions. With the rise of DOACs such as rivaroxaban, the opportunity for abuse also increases. Therefore, standardization of care based on rivaroxaban misuse must also be explored, an area in which there is not ample information. We present a case where a patient consumed a stockpile of her home medications in hopes to commit suicide. A 64-year-old female presented to the emergency department due to the ingestion of rivaroxaban 5,000 mg along with ingestion of acetaminophen 30,000 mg and isosorbide mononitrate 1000 mg in the setting of intentional self-harm with multiple declarations of being classified as Do Not Resuscitate. There have been documented cases of rivaroxaban overdose, however, there are no documented cases with levels of ingestion reaching 5,000 mg along with signs of severe bleeding. Our case study reviews the previously documented management of rivaroxaban abuse and the treatment that was given to our patient in the setting of extreme anticoagulant ingestion. Cureus 2023-01-20 /pmc/articles/PMC9939290/ /pubmed/36814751 http://dx.doi.org/10.7759/cureus.34019 Text en Copyright © 2023, Casey et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Cardiology Casey, Bradley Daniels, Abigail Bahekar, Amol Patel, Divyang Chapa-Rodriguez, Alejandro Management of Massive Rivaroxaban Overdose With Acetaminophen and Isosorbide Mononitrate Overdose |
title | Management of Massive Rivaroxaban Overdose With Acetaminophen and Isosorbide Mononitrate Overdose |
title_full | Management of Massive Rivaroxaban Overdose With Acetaminophen and Isosorbide Mononitrate Overdose |
title_fullStr | Management of Massive Rivaroxaban Overdose With Acetaminophen and Isosorbide Mononitrate Overdose |
title_full_unstemmed | Management of Massive Rivaroxaban Overdose With Acetaminophen and Isosorbide Mononitrate Overdose |
title_short | Management of Massive Rivaroxaban Overdose With Acetaminophen and Isosorbide Mononitrate Overdose |
title_sort | management of massive rivaroxaban overdose with acetaminophen and isosorbide mononitrate overdose |
topic | Cardiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939290/ https://www.ncbi.nlm.nih.gov/pubmed/36814751 http://dx.doi.org/10.7759/cureus.34019 |
work_keys_str_mv | AT caseybradley managementofmassiverivaroxabanoverdosewithacetaminophenandisosorbidemononitrateoverdose AT danielsabigail managementofmassiverivaroxabanoverdosewithacetaminophenandisosorbidemononitrateoverdose AT bahekaramol managementofmassiverivaroxabanoverdosewithacetaminophenandisosorbidemononitrateoverdose AT pateldivyang managementofmassiverivaroxabanoverdosewithacetaminophenandisosorbidemononitrateoverdose AT chaparodriguezalejandro managementofmassiverivaroxabanoverdosewithacetaminophenandisosorbidemononitrateoverdose |